Galcanezumab is a welcome option for patients who have grown frustrated with currently available treatment options, one headache expert said. Medscape Medical News Source link
[ad_1] Dr Deborah Friedman reviews the new anti-CGRP monoclonal antibodies for migraine prevention. American Headache Society and Medscape Source link [ad_2]
© 2017 Worldnews Media LLC. All Rights Reserved.